Michael J. Banker

645 total citations
6 papers, 364 citations indexed

About

Michael J. Banker is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Michael J. Banker has authored 6 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Pharmacology. Recurrent topics in Michael J. Banker's work include Glycosylation and Glycoproteins Research (1 paper), Protein Interaction Studies and Fluorescence Analysis (1 paper) and Research on Leishmaniasis Studies (1 paper). Michael J. Banker is often cited by papers focused on Glycosylation and Glycoproteins Research (1 paper), Protein Interaction Studies and Fluorescence Analysis (1 paper) and Research on Leishmaniasis Studies (1 paper). Michael J. Banker collaborates with scholars based in United States and Czechia. Michael J. Banker's co-authors include Tracey Clark, John A. Williams, Michael D. Aleo, John W. Benbow, Jiri Aubrecht, David O. Nettleton, David A. Andow and Kristen C. Nelson and has published in prestigious journals such as Nature Biotechnology, Gene and Journal of Pharmaceutical Sciences.

In The Last Decade

Michael J. Banker

6 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Banker United States 6 189 87 70 50 49 6 364
Robert J. Edwards United Kingdom 8 166 0.9× 110 1.3× 205 2.9× 32 0.6× 29 0.6× 11 359
Е.O. Yablokov Russia 11 151 0.8× 38 0.4× 107 1.5× 39 0.8× 37 0.8× 48 337
Karishma Patel Australia 10 250 1.3× 143 1.6× 35 0.5× 37 0.7× 42 0.9× 24 512
Teresa Tam Canada 11 305 1.6× 72 0.8× 77 1.1× 25 0.5× 37 0.8× 20 733
Jianyu Li China 13 270 1.4× 70 0.8× 83 1.2× 66 1.3× 98 2.0× 38 522
Sara Belli Switzerland 14 257 1.4× 125 1.4× 23 0.3× 30 0.6× 33 0.7× 22 444
Janet M. Kolb United States 13 262 1.4× 58 0.7× 38 0.5× 16 0.3× 31 0.6× 15 432
Thomas J. Mikkelson United States 12 122 0.6× 60 0.7× 58 0.8× 19 0.4× 72 1.5× 15 511
M.G. Rowlands United Kingdom 16 294 1.6× 169 1.9× 115 1.6× 18 0.4× 48 1.0× 30 676
Schroeder M. Noble United States 9 202 1.1× 107 1.2× 226 3.2× 35 0.7× 27 0.6× 15 507

Countries citing papers authored by Michael J. Banker

Since Specialization
Citations

This map shows the geographic impact of Michael J. Banker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Banker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Banker more than expected).

Fields of papers citing papers by Michael J. Banker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Banker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Banker. The network helps show where Michael J. Banker may publish in the future.

Co-authorship network of co-authors of Michael J. Banker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Banker. A scholar is included among the top collaborators of Michael J. Banker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Banker. Michael J. Banker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Benbow, John W., Jiri Aubrecht, Michael J. Banker, David O. Nettleton, & Michael D. Aleo. (2010). Predicting safety toleration of pharmaceutical chemical leads: Cytotoxicity correlations to exploratory toxicity studies☆. Toxicology Letters. 197(3). 175–182. 36 indexed citations
2.
Nelson, Kristen C., David A. Andow, & Michael J. Banker. (2009). Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms. The Journal of Law Medicine & Ethics. 37(4). 732–748. 18 indexed citations
3.
Banker, Michael J. & Tracey Clark. (2008). Plasma / Serum Protein Binding Determinations. Current Drug Metabolism. 9(9). 854–859. 68 indexed citations
4.
Banker, Michael J., Tracey Clark, & John A. Williams. (2003). Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding. Journal of Pharmaceutical Sciences. 92(5). 967–974. 218 indexed citations
5.
Banker, Michael J., et al.. (1989). Enhanced Expression of an Immunoglobulin-Based Vector in Myeloma Cells Mediated by Coamplification with a Mutant Dihydrofolate Reductase Gene. Nature Biotechnology. 7(12). 1271–1274. 9 indexed citations
6.
Banker, Michael J., et al.. (1988). A high-efficiency vector for expression of foreign genes in myeloma cells. Gene. 64(1). 43–51. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026